[ad_1]
World Asset Management Inc reduced its stake in Icon Plc (NASDAQ: ICLR) by 24.9% in the second quarter, according to its most recent deposit with The Fund held 1,615 shares of the medical research company after selling 535 shares during the 2009 quarter. World Asset Management Inc.'s holdings in Icon sank at $ 214,000 at the end of the most recent reporting period.
Cambiar Investors LLC increased its stake in Icon's shares by 9.9% in the second quarter of 2007. Cambiar Investors LLC now owns 4,498 shares of the medical research business valued at $ 596,000 after the purchase of another 405 shares during the last quarter Fox Run Management LLC bought a new position in the shares of Icon in the second quarter worth about $ 422,000. Icon's 4.8% in the 2nd quarter. Bank of Montreal can now hold 177,327 shares in the medical research business valued at $ 23,501,000 after purchasing 8,093 additional shares in the last quarter. Atria Investments LLC increased its stake in Icon shares by 28.3% in the 2nd quarter. Atria Investments LLC now holds 5,532 shares of the medical research business valued at $ 733,000 following the purchase of an additional 1,220 shares during the last quarter. Finally, Campbell & CO Investment Adviser LLC bought a new position in Icon shares in the second quarter, valued at around $ 390,000. Institutional investors own 87.10% of the shares of the company.
Icon open at $ 141.00 on Friday, reports MarketBeat Ratings. The company has a current ratio of 1.85, a ratio of 1.85 and a debt ratio of 0.29. Icon Plc has a minimum of $ 101.00 in one year and $ 146.31 in one year. The company has a market capitalization of $ 7.57 billion, a P / E ratio of 26.16, a price / earnings ratio of 2.19 and a beta of 0.45.
Icon (NASDAQ: ICLR) released its quarterly results for the last time on Wednesday, July 25. The medical research company reported $ 1.31 in earnings per share for the quarter, missing Zacks' consensus estimate of $ 1.48 per ($ 0.17). Icon had a net margin of 13.69% and a return on equity of 26.71%. During the quarter, the company achieved a business turnover of $ 641.60 million, compared with $ 618.64 million for badysts. During the same quarter last year, the company earned $ 1.34 per share. The quarterly business turnover of the company increased by 48.9% compared to the same quarter of last year. stock badysts predict that Ivis Plc will post earnings per share of 6.05 for the current year.
Several research badysts have weighed on ICLR shares. BidaskClub downgraded the icon from a "buy" rating to a "keep" rating in a research note on Friday, April 6th. Zacks Investment Research upgraded the Icon from a "hold" rating to a "buy" rating and set a target price of $ 134.00 on the stock in a research note on Wednesday, April 18th. Jefferies Financial Group raised its target price on Icon to $ 150.00 and awarded the company a "buy" rating in a research note on Friday, June 1st. KeyCorp raised its target price on Icon from $ 130.00 to $ 152.00 and awarded the company an "overweight" rating in a research note on Monday, June 18th. Finally, Credit Suisse Group raised its target price on Icon from $ 131.00 to $ 144.00 and awarded the company an "outperformance" rating in a research note on Tuesday, June 19th. Two equity research badysts gave a rating to the stock, nine issued a purchase rating and one attributed a strong rating to the company's stock. Icon has a consensual rating of "Buy" and a consensus price target of $ 138.80
Icon Profile
ICON Public Limited Company, a clinical research organization, provides development services outsourced to the pharmaceutical, biotechnology and medical device industries in Ireland, in the rest of Europe, the United States and abroad. He specializes in the strategic development, management and badysis of programs that support the different stages of the clinical development process, from compound selection to phase I to IV clinical studies
History: Dividend ]
to see what other hedge funds hold ICLR? Visit HoldingsChannel.com to get the latest deposits and 13F insider trading for Icon Plc (NASDAQ: ICLR).
Receive news and current information on Icon Daily – Enter your email address below to receive a summary daily concise latest news for Icon and badociated companies with MarketBeat.com's free daily newsletter.
Source link
